Mitchell C. Benson

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Suk Hyung Lee, Wenhuo Hu, Justin T. Matulay et al. · Cell · 2018 · 825 citations · Full text

Tumor Biology, Urology, Oncology +11

Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer

Mitchell C. Benson, Ihn Seong Whang, Allan J. Pantuck et al. · The Journal of Urology · 1992 · 767 citations

Urology, Prostate Disease, Genitourinary Cancer +8

The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific Antigen

Mitchell C. Benson, Ihn Seong Whang, Carl A. Olsson et al. · The Journal of Urology · 1992 · 610 citations

Prostate Volumes, Engineering, Diagnosis +18

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Marc Colombel, Fraser Symmans, Sixtina Gil et al. · PubMed · 1993 · 595 citations · Full text